Literature DB >> 27975242

Global Conformation of Tau Protein Mapped by Raman Spectroscopy.

Nalini Vijay Gorantla1,2, Puneet Khandelwal2,3, Pankaj Poddar2,3, Subashchandrabose Chinnathambi4,5.   

Abstract

Alzheimer's disease (AD) is one of the neurodegenerative disease characterized by progressive neuronal loss in the brain. Its two major hallmarks are extracellular senile plaques and intracellular neurofibrillary tangles (NFTs), formed by aggregation of amyloid β-42 (Aβ-42) and Tau protein respectively. Aβ-42 is a transmembrane protein, which is produced after the sequential action of β- and γ-secretases, thus obtained peptide is released extracellularly and gets deposited on the neuron forming senile plaques. NFTs are composed of microtubule-associated protein-Tau (MAPT). Tau protein's major function is to stabilize the microtubule that provides a track on which the cargo proteins are shuttled and the stabilized microtubule also maintains shape and integrity of the neuronal cell. Tau protein is subjected to various modifications such as phosphorylation, ubiquitination, glycation, acetylation, truncation, glycosylation, deamination, and oxidation; these modifications ultimately lead to its aggregation. Phosphorylation is the major modification and is extensively studied with respect to Tau protein. Tau protein, however, undergoes certain level of phosphorylation and dephosphorylation, which regulates its affinity for microtubule and ultimately leading to microtubule assembly and disassembly. Our main aim was to study the native state of longest isoform of Tau (hTau40WT-4R2N) and its shortest isoform, (hTau23WT-3R0N), at various temperatures such as 10, 25, and 37 °C. Raman spectroscopic results suggested that the proportion of random coils or unordered structure depends on the temperature of the protein environment. Upon increase in the temperature from 10 to 37 °C, the proportion of random coils or unordered structures increased in the case of hTau40WT. However, we did not find a significant effect of temperature on the structure of hTau23WT. This current approach enables one to analyze the global conformation of soluble Tau in solution.

Entities:  

Keywords:  Alzheimer disease; Raman spectroscopy; Sedimentation assay; Tau aggregation; Tau conformation; Tau protein

Mesh:

Substances:

Year:  2017        PMID: 27975242     DOI: 10.1007/978-1-4939-6598-4_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

Review 1.  Mammalian cell and tissue imaging using Raman and coherent Raman microscopy.

Authors:  Anthony A Fung; Lingyan Shi
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2020-07-19

2.  Retention of Anticancer Activity of Curcumin after Conjugation with Fluorescent Gold Quantum Clusters: An in Vitro and in Vivo Xenograft Study.

Authors:  Puneet Khandelwal; Aftab Alam; Arpankumar Choksi; Samit Chattopadhyay; Pankaj Poddar
Journal:  ACS Omega       Date:  2018-05-01

3.  Photoexcited Toluidine Blue Inhibits Tau Aggregation in Alzheimer's Disease.

Authors:  Tushar Dubey; Nalini Vijay Gorantla; Kagepura Thammaiah Chandrashekara; Subashchandrabose Chinnathambi
Journal:  ACS Omega       Date:  2019-10-29

4.  Basic Limonoid modulates Chaperone-mediated Proteostasis and dissolve Tau fibrils.

Authors:  Nalini Vijay Gorantla; Rashmi Das; Hariharakrishnan Chidambaram; Tushar Dubey; Fayaj A Mulani; Hirekodathakallu V Thulasiram; Subashchandrabose Chinnathambi
Journal:  Sci Rep       Date:  2020-03-04       Impact factor: 4.379

5.  Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.

Authors:  Shweta Kishor Sonawane; Vladimir N Uversky; Subashchandrabose Chinnathambi
Journal:  Cell Commun Signal       Date:  2021-02-12       Impact factor: 5.712

6.  Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation.

Authors:  Rashmi Das; Abhishek Ankur Balmik; Subashchandrabose Chinnathambi
Journal:  ASN Neuro       Date:  2020 Jan-Dec       Impact factor: 4.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.